'
SCIENTIFIC SCORE
Moderately Effective
Based on 18 Researches
8.1
USERS' SCORE
Good
Based on 8 Reviews
8.6
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Saccharomyces boulardii(an S. cerevisiae Strain)
250 mg(5 Billion CFU)
MOS Yeast Fraction(Min. 35% Manno-oligosaccharides [MOS]) (S. cerevisiae)
200 mg

Top Medical Research Studies

8
Saccharomyces boulardii improves liver health
Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.
Significant findings in liver treatment
We explored the effects of Saccharomyces boulardii on liver fibrosis caused by carbon tetrachloride in 34 male Wistar rats. The rats were divided into different groups, including controls and those receiving treatment.

Our findings showed that S. boulardii reduced liver damage markers and levels of inflammatory substances in the treated group. This beneficial effect was linked to improved intestinal health and changes in gut bacteria. Overall, we observed that administering this probiotic can enhance liver function and slow down fibrosis progression.
Read More
9
Saccharomyces boulardii reduces liver fat
Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.
Moderately relevant findings
We explored how Saccharomyces boulardii might alleviate non-alcoholic fatty liver disease (NAFLD) in rats suffering from fructose-induced liver damage. Thirty rats were divided into control, fatty liver, and treatment groups.

Our findings revealed that the rats receiving S. boulardii showed lower levels of harmful substances and improved liver health indicators compared to those without treatment. Notably, there was less fat buildup in their livers.

This suggests that S. boulardii could serve as a promising way to protect the liver from fatty damage linked to high fructose diets.
Read More
9
Saccharomyces boulardii prevents liver injury
Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection.
Highly relevant findings presented
We explored how Saccharomyces boulardii can protect the liver from damage caused by Salmonella Enteritidis. In a mouse study, we saw that pretreating with S. boulardii drastically reduced the movement of harmful bacteria to the liver by 96%, preventing significant hepatic injury. S. boulardii also minimized inflammatory responses that would typically harm liver tissue after infection. These findings suggest that S. boulardii could be a valuable tool for guarding against liver injury due to Salmonella infections in future treatments.
Read More

Most Useful Reviews

9.5
Complementary therapy
I find S. Boulardii essential for prevention and treatment. It modifies the intestinal microbiota, reduces body fat, and aids liver disease. It effectively treats constipation, diarrhoea, giardiasis, and fungal infections. I believe it's a crucial addition to basic therapy for various conditions.
Read More
9.5
Crohn's remission
I highly recommend this probiotic; I would give it ten stars if possible. My husband suffers from severe Crohn's Disease, and this product has put it in remission. It has significantly improved his quality of life amid his liver disease diagnosis. Truly remarkable!
Read More
6.3
Family health support
With enterovirus diseases, this product worked wonders for my children. I advise its use, especially considering my own experience with liver disease.
Read More

Medical Researches

SCIENTIFIC SCORE
Moderately Effective
Based on 18 Researches
8.1
9
Saccharomyces boulardii reduces liver fat
Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.
Moderately relevant findings
We explored how Saccharomyces boulardii might alleviate non-alcoholic fatty liver disease (NAFLD) in rats suffering from fructose-induced liver damage. Thirty rats were divided into control, fatty liver, and treatment groups.

Our findings revealed that the rats receiving S. boulardii showed lower levels of harmful substances and improved liver health indicators compared to those without treatment. Notably, there was less fat buildup in their livers.

This suggests that S. boulardii could serve as a promising way to protect the liver from fatty damage linked to high fructose diets.
Read More
9
Probiotics may improve cirrhosis outcomes
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial.
Findings indicate potential treatment benefits
We investigated whether probiotics could positively influence patients with cirrhosis. In our randomized placebo-controlled trial involving 40 participants, we found that those taking probiotics experienced improvements in circulation and symptoms associated with cirrhosis.

Specifically, patients showed reduced cardiac output, increased vascular resistance, and better liver function. Those receiving probiotics also had fewer complications, such as ascites and hepatic encephalopathy.

Overall, our findings suggest that probiotics may offer a beneficial effect on the management of cirrhosis.
Read More
9
Saccharomyces boulardii prevents liver injury
Saccharomyces boulardii prevention of the hepatic injury induced by Salmonella Enteritidis infection.
Highly relevant findings presented
We explored how Saccharomyces boulardii can protect the liver from damage caused by Salmonella Enteritidis. In a mouse study, we saw that pretreating with S. boulardii drastically reduced the movement of harmful bacteria to the liver by 96%, preventing significant hepatic injury. S. boulardii also minimized inflammatory responses that would typically harm liver tissue after infection. These findings suggest that S. boulardii could be a valuable tool for guarding against liver injury due to Salmonella infections in future treatments.
Read More
9
S. boulardii protects liver health
Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats.
High relevance for liver protection
We explored how Saccharomyces boulardii impacts rats treated with clarithromycin and methotrexate, both of which can cause liver and intestinal injury. In our study, rats receiving these drugs showed increased gut transit and marked oxidative damage.

However, those treated with S. boulardii experienced protection from these harmful effects. The probiotic not only improved antioxidant levels but also reduced inflammation in the liver and intestines.

These findings suggest that S. boulardii may serve as a useful addition to chemotherapy, helping to safeguard liver health during treatment.
Read More
8
Saccharomyces boulardii shows promise
Effect of on Liver Diseases: A Systematic Review.
High relevance due to significant findings
We systematically reviewed studies on the effects of Saccharomyces boulardii (SB) in treating liver diseases. Our analysis included sixteen studies, comprising ten animal experiments and six randomized controlled trials. We found that SB effectively lowered the severity of cirrhosis symptoms and improved liver health metrics.

Additionally, SB significantly reduced inflammatory markers and gene expressions associated with liver injury in various models. It also showed benefits in gut health by altering microbiota composition and enhancing barrier function. Overall, SB displays potential for supporting liver health, especially in cirrhosis and metabolic dysfunction.
Read More

User Reviews

USERS' SCORE
Good
Based on 8 Reviews
8.6
9.5
Complementary therapy
I find S. Boulardii essential for prevention and treatment. It modifies the intestinal microbiota, reduces body fat, and aids liver disease. It effectively treats constipation, diarrhoea, giardiasis, and fungal infections. I believe it's a crucial addition to basic therapy for various conditions.
Read More
9.5
Crohn's remission
I highly recommend this probiotic; I would give it ten stars if possible. My husband suffers from severe Crohn's Disease, and this product has put it in remission. It has significantly improved his quality of life amid his liver disease diagnosis. Truly remarkable!
8.8
Liver improvement
Medicine recognises the benefits of saccharomycetes in diabetes and obesity. This yeast promptly alters the intestinal microbiota, reducing body fat and improving liver disease. Prophylactic use of S. Boulardii also lowers the risk of coronary heart disease. The capsules are of excellent quality and are easy to swallow, making them one of my favourites.
Read More
8.8
Effective for liver disease
This unique probiotic has proven benefits for the gastrointestinal tract, supported by clinical studies. It enhances the immune system and alleviates acute diarrhoea in children and adults. Saccharomycetes are effective against liver disease, as they alter the intestinal microbiota, lowering body fat. The product has proven helpful in treating constipation, diarrhoea, giardiasis, and liver disease. Highly recommended!
Read More
8.8
Strengthening immunity
Saccharomycetes boulardii supports the immune system and alleviates acute diarrhoea. The yeast changes the intestinal microbiota, which aids in reducing body fat and improves liver disease. Additionally, it diminishes toxin effects and enhances digestive enzyme activity. This product is a lifesaver!
Read More
image